1 interaction related to hemp extract
CBD (cannabidiol) can raise blood levels of oral drugs handled by the P-glycoprotein (P-gp) transporter, and cyclosporine is a P-gp substrate. The Epidiolex (prescription CBD) label says exposure to orally taken P-gp substrates such as sirolimus and tacrolimus may increase and advises drug-level monitoring and dose reduction; it does not name cyclosporine, but CBD raised exposure to everolimus, another transplant drug handled by P-gp, about 2.5-fold in healthy adults, while it did not change levels of midazolam, a CYP3A4 test drug. A case report described a pharmacokinetic interaction between CBD and cyclosporine in a kidney transplant recipient, but its abstract gives no numbers, so the size of the effect is not known.